Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
O'Sullivan
S S
SS
Cronin
E M
EM
Sweeney
B J
BJ
Bourke
J F
JF
Fitzgibbon
J
J
D000273:Adipose Tissue / Q000473:pathology*; D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D001284:Atrophy / Q000139:chemically induced; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D015434:Panniculitis / Q000139:chemically induced*; D011994:Recombinant Proteins
D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta